Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
ABC-AF Bleeding ScoreABC-AF Stroke ScoreABCD2 ScoreADD-RSAortic Valve Calcium ScoreAPPLE ScoreASCVD (Pooled Cohort)AVA (Continuity Equation)BAG-AHF ScoreBiplane Simpson EFBlood Pressure PercentilesBrugada Criteria (VT vs SVT)Cardiac Output IndexCHA2DS2-VAScCHADS2Cornell Voltage CriteriaCRUSADE Bleeding ScoreDAPT ScoreDASIDuke Treadmill ScoreE/A RatioEDACS ScoreEHMRGEHRA ScoreEmbolic Risk ScoreEROA (PISA Method)FFR (Fractional Flow Reserve)Fick Cardiac OutputFramingham 10-Year RiskFriedewald LDL EquationGorlin EquationGRACE ScoreGupta MICA (NSQIP)GWTG-HF ScoreH2FPEF ScoreHakki FormulaHAS-BLEDHEART PathwayHEART ScoreHEMORR2HAGEShs-Troponin 0h/1h ESC AlgorithmiFRINTERCHEST ScoreKillip ClassificationLee's RCRILV Mass IndexLV Stroke Work IndexMAGGIC Risk ScoreMAP CalculatorMartin/Hopkins LDLModified Duke CriteriaModified Sgarbossa CriteriaMVA (Pressure Half-Time)Non-HDL CholesterolNT-proBNP Age-Adjusted ThresholdsORBIT ScoreOttawa Heart Failure RiskPREVENT EquationsPulse PressurePVR CalculatorPVR IndexQRISK3QTc (Bazett)QTc (Fridericia)REVEAL 2.0 ScoreREVEAL Lite 2Reynolds Risk ScoreROSIRVSP CalculatorSchwartz Score (LQTS)SCORE2Seattle Heart Failure Model (SHFM)Sgarbossa CriteriaShock IndexSokolow-Lyon VoltageStroke Volume IndexSVR CalculatorSYNTAX ScoreSYNTAX Score IITAPSETeichholz FormulaTIMI (STEMI)TIMI (UA/NSTEMI)Troponin Delta CalculatorValvular GradientsVancouver Chest Pain RuleVereckei AlgorithmWATCHDM ScoreWilkins ScoreWood Units Calculator
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2026

•

All Rights Reserved

FFR (Fractional Flow Reserve)

FFR (Fractional Flow Reserve): Pressure-wire derived index to assess functional significance of coronary lesions.

Formula

FFR = Pd / Pa

Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

When to Use

Functional assessment of coronary lesion severity during angiography
Decision-making: proceed with PCI vs. defer in intermediate stenosis
Multivessel disease triage (defer non-culprit lesions if FFR >0.80)
Guidance for staged revascularization strategy
≥50% but <90% angiographic stenosis requiring physiologic assessment

Key Points

FFR 0.75–0.80: borderline lesions benefit from serial assessment or iFR
FFR-guided PCI reduces MACE vs. angiography-only guided strategy
ESC/AHA recommend FFR for intermediate coronary lesions
Requires adenosine hyperaemia or equivalent stress; adenosine-free alternatives (iFR, RFR) emerging

How it Works

Formula

FFR = Pd/Pa at maximal hyperaemia Pd = distal coronary pressure (beyond lesion) Pa = aortic pressure (proximal) Normal FFR = 1.0 (no pressure drop) FFR <0.80 = functionally significant lesion (ischaemic)

Interpretation

FFR ValueClinical SignificanceRecommendation
≥0.80Not ischaemicDefer PCI; medical therapy
0.75–0.80BorderlineConsider serial or iFR
<0.75IschaemicPCI recommended
<0.50Severe ischaemiaPCI strongly indicated

Clinical Pearls

Technical Pearls

Adenosine dose: 140–180 µg/kg/min IV (preferred); or 12–18 µg IC per vessel
Ensure true hyperaemia by observing ≥50% HR increase or equalization of distal/aortic pressures
Avoid nitroglycerin interference; check baseline Pd/Pa ratio pre-hyperaemia
Serial stenosis: pullback pressure tracing identifies contribution of each lesion

Clinical Gotchas

Microvascular dysfunction (diabetes, HFpEF) → falsely low FFR despite epicardial disease
Tandem lesions: FFR measures combined effect; difficult to attribute ischaemia to single lesion
Left main stenosis: FFR may underestimate true ischaemic burden
Chronic total occlusions: FFR not reliable for viability assessment

Next Steps

FFR ≥0.80 (Not Ischaemic)

Defer PCI; medical therapy optimisation
Serial angiography at 6–12 months if high-risk features
Repeat FFR if anatomy changes or symptoms worsen
Culprit lesion PCI still appropriate if acute presentation

FFR 0.75–0.80 (Borderline)

Consider iFR (rest pressure ratio index) for confirmation
Conservative management if stable chronic CAD
Stress testing to correlate with objective ischaemia
Close follow-up; repeat FFR if lesion progression suspected

FFR <0.75 (Ischaemic)

PCI with modern stent (DES) recommended
Dual antiplatelet therapy ≥12 months (standard)
Serial follow-up catheterism if DAPT not tolerated
Consider multivessel FFR-guided revascularisation strategy

Complementary Calculators

iFR Calculator
SYNTAX Score
Duke Treadmill Score
DAPT Score
Cardiac Output Index

The Evidence

Landmark Trials

Origins & History

Development

Developed by Prof. Nico Pijls (Maastricht, Netherlands) and Dr. Bernard De Bruyne (Brugge, Belgium) in the late 1990s. FFR-guided PCI has become standard practice, endorsed by all major cardiology guidelines for functional lesion assessment.

Last Comprehensive Review: 2026-07-17

Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

When to Use

Functional assessment of coronary lesion severity during angiography
Decision-making: proceed with PCI vs. defer in intermediate stenosis
Multivessel disease triage (defer non-culprit lesions if FFR >0.80)
Guidance for staged revascularization strategy
≥50% but <90% angiographic stenosis requiring physiologic assessment

Key Points

FFR 0.75–0.80: borderline lesions benefit from serial assessment or iFR
FFR-guided PCI reduces MACE vs. angiography-only guided strategy
ESC/AHA recommend FFR for intermediate coronary lesions
Requires adenosine hyperaemia or equivalent stress; adenosine-free alternatives (iFR, RFR) emerging

How it Works

Formula

FFR = Pd/Pa at maximal hyperaemia Pd = distal coronary pressure (beyond lesion) Pa = aortic pressure (proximal) Normal FFR = 1.0 (no pressure drop) FFR <0.80 = functionally significant lesion (ischaemic)

Interpretation

FFR ValueClinical SignificanceRecommendation
≥0.80Not ischaemicDefer PCI; medical therapy
0.75–0.80BorderlineConsider serial or iFR
<0.75IschaemicPCI recommended
<0.50Severe ischaemiaPCI strongly indicated

Clinical Pearls

Technical Pearls

Adenosine dose: 140–180 µg/kg/min IV (preferred); or 12–18 µg IC per vessel
Ensure true hyperaemia by observing ≥50% HR increase or equalization of distal/aortic pressures
Avoid nitroglycerin interference; check baseline Pd/Pa ratio pre-hyperaemia
Serial stenosis: pullback pressure tracing identifies contribution of each lesion

Clinical Gotchas

Microvascular dysfunction (diabetes, HFpEF) → falsely low FFR despite epicardial disease
Tandem lesions: FFR measures combined effect; difficult to attribute ischaemia to single lesion
Left main stenosis: FFR may underestimate true ischaemic burden
Chronic total occlusions: FFR not reliable for viability assessment

Next Steps

FFR ≥0.80 (Not Ischaemic)

Defer PCI; medical therapy optimisation
Serial angiography at 6–12 months if high-risk features
Repeat FFR if anatomy changes or symptoms worsen
Culprit lesion PCI still appropriate if acute presentation

FFR 0.75–0.80 (Borderline)

Consider iFR (rest pressure ratio index) for confirmation
Conservative management if stable chronic CAD
Stress testing to correlate with objective ischaemia
Close follow-up; repeat FFR if lesion progression suspected

FFR <0.75 (Ischaemic)

PCI with modern stent (DES) recommended
Dual antiplatelet therapy ≥12 months (standard)
Serial follow-up catheterism if DAPT not tolerated
Consider multivessel FFR-guided revascularisation strategy

Complementary Calculators

iFR Calculator
SYNTAX Score
Duke Treadmill Score
DAPT Score
Cardiac Output Index

The Evidence

Landmark Trials

Origins & History

Development

Developed by Prof. Nico Pijls (Maastricht, Netherlands) and Dr. Bernard De Bruyne (Brugge, Belgium) in the late 1990s. FFR-guided PCI has become standard practice, endorsed by all major cardiology guidelines for functional lesion assessment.

Last Comprehensive Review: 2026-07-17

In Recent Clinical News

Scanning Medical Journals

No new significant updates or guidelines matching this topic were found today. We will check again soon.